Insider Trading History of Khosla Chaitan Phd

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Khosla Chaitan Phd since 2006. The trader's CIK number is 1135139. At the time of the last reporting, Khosla Chaitan Phd was the Director of Protagonist Therapeutics, Inc. (stock ticker symbol PTGX). Also see all insider trading activities at Protagonist Therapeutics, Inc.

Note that in the past KHOSLA CHAITAN PHD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Kosan Biosciences Inc (KOSN) by Khosla Chaitan Phd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 KOSN 0 $0 50,000 $263,050 0 $0
2006 KOSN 0 $0 16,792 $93,468 0 $0

Yearly summary of insider trading at Protagonist Therapeutics, Inc (PTGX) by Khosla Chaitan Phd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 PTGX 0 $0 2,499 $42,952 2,499 $4,723


Insider trading activities at 2 companies by Khosla Chaitan Phd:

1. Kosan Biosciences Inc (KOSN)

2. Protagonist Therapeutics, Inc (PTGX)

Table 1. Insider trading of Kosan Biosciences Inc (KOSN) by Khosla Chaitan Phd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-03-26 KOSN Sale 50,000 5.26 263,050
2006-04-18 KOSN Sale 3,200 5.41 17,296
2006-04-17 KOSN Sale 3,200 5.71 18,284
2006-03-14 KOSN Sale 3,200 5.92 18,953
2006-03-15 KOSN Sale 3,200 5.93 18,972
2006-02-09 KOSN Sale 792 5.00 3,963
2006-02-08 KOSN Sale 3,200 5.00 16,000

Table 2. Insider trading of Protagonist Therapeutics, Inc (PTGX) by Khosla Chaitan Phd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-08-11 PTGX Sale 2,499 17.19 42,952
2020-08-11 PTGX Option Ex 2,499 1.89 4,723

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Khosla Chaitan Phd (Director of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.